Nanoparticulate topiramate formulations

Details Nanoparticulate topiramate formulations Nanoparticulate topiramate formulations

2008-06-24

2008-06-24

Richter, Johann R. (Department: 1616)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

C514S449000

Reexamination Certificate

active

07390505

ABSTRACT:
The present invention is directed to nanoparticulate compositions comprising topiramate. The topiramate particles of the composition have an effective average particle size of less than about 2 microns.

REFERENCES:
patent: 4783484 (1988-11-01), Violante et al.
patent: 4826689 (1989-05-01), Violanto et al.
patent: 4997454 (1991-03-01), Violante et al.
patent: 5145684 (1992-09-01), Liversidge et al.
patent: 5298262 (1994-03-01), Na et al.
patent: 5302401 (1994-04-01), Liversidge et al.
patent: 5318767 (1994-06-01), Liversidge et al.
patent: 5326552 (1994-07-01), Na et al.
patent: 5328404 (1994-07-01), Bacon
patent: 5336507 (1994-08-01), Na et al.
patent: 5340564 (1994-08-01), Illig et al.
patent: 5346702 (1994-09-01), Na et al.
patent: 5349957 (1994-09-01), Yudelson
patent: 5352459 (1994-10-01), Hollister et al.
patent: 5399363 (1995-03-01), Liversidge et al.
patent: 5401492 (1995-03-01), Kellar et al.
patent: 5429824 (1995-07-01), June
patent: 5447710 (1995-09-01), Na et al.
patent: 5451393 (1995-09-01), Liversidge et al.
patent: 5466440 (1995-11-01), Ruddy et al.
patent: 5470583 (1995-11-01), Na et al.
patent: 5472683 (1995-12-01), Illig
patent: 5494683 (1996-02-01), Liversidge et al.
patent: 5500204 (1996-03-01), Osifo
patent: 5510118 (1996-04-01), Bosch et al.
patent: 5518187 (1996-05-01), Bruno et al.
patent: 5518738 (1996-05-01), Eickhoff et al.
patent: 5521218 (1996-05-01), Osifo
patent: 5525328 (1996-06-01), Bacon et al.
patent: 5534270 (1996-07-01), De Castro
patent: 5543133 (1996-08-01), Swanson et al.
patent: 5552160 (1996-09-01), Liversidge et al.
patent: 5560931 (1996-10-01), Eickhoff et al.
patent: 5560932 (1996-10-01), Bagchi et al.
patent: 5565188 (1996-10-01), Wong et al.
patent: 5569448 (1996-10-01), Wong et al.
patent: 5571536 (1996-11-01), Eickhoff et al.
patent: 5573749 (1996-11-01), Illig
patent: 5573750 (1996-11-01), Singh
patent: 5573783 (1996-11-01), Desieno et al.
patent: 5580579 (1996-12-01), Ruddy et al.
patent: 5585108 (1996-12-01), Ruddy et al.
patent: 5587143 (1996-12-01), Wong
patent: 5591456 (1997-01-01), Franson et al.
patent: 5593657 (1997-01-01), Ruddy et al.
patent: 5622938 (1997-04-01), Wong
patent: 5628981 (1997-05-01), Liversidge et al.
patent: 5643552 (1997-07-01), Illig
patent: 5662883 (1997-09-01), Bagchi et al.
patent: 5665331 (1997-09-01), Bagchi et al.
patent: 5718388 (1998-02-01), Czekai et al.
patent: 5718919 (1998-02-01), Ruddy et al.
patent: 5741522 (1998-04-01), Violante et al.
patent: 5747001 (1998-05-01), Wiedmann et al.
patent: 5776496 (1998-07-01), Violante et al.
patent: 5834025 (1998-11-01), De Garavilla et al.
patent: 5862999 (1999-01-01), Czekai et al.
patent: 6045829 (2000-04-01), Liversidge et al.
patent: 6068858 (2000-05-01), Liversidge et al.
patent: 6153225 (2000-11-01), Lee et al.
patent: 6165506 (2000-12-01), Jain et al.
patent: 6207197 (2001-03-01), Ilum et al.
patent: 6221400 (2001-04-01), Liversidge et al.
patent: 6264922 (2001-07-01), Wood et al.
patent: 6267989 (2001-07-01), Liversidge et al.
patent: 6270806 (2001-08-01), Liversidge et al.
patent: 6316029 (2001-11-01), Jain et al.
patent: 6375986 (2002-04-01), Ryde et al.
patent: 6428814 (2002-08-01), Bosch
patent: 6431478 (2002-08-01), Reed et al.
patent: 6432381 (2002-08-01), Liversidge et al.
patent: 6582285 (2003-06-01), Czekai et al.
patent: 6592903 (2003-07-01), Ryde et al.
patent: 6656504 (2003-12-01), Bosch et al.
patent: 6696091 (2004-02-01), Thakur et al.
patent: 2002/0012675 (2002-01-01), Jain et al.
patent: 2002/0110597 (2002-08-01), Ryde et al.
patent: 2004/0258757 (2004-12-01), Bosch et al.
patent: 2005/0244503 (2005-11-01), Rabinow et al.
patent: WO 00/72973 (2000-12-01), None
patent: WO 02/098565 (2002-12-01), None
Bray et al., “A 6-Month Radonmized, Placebo-Controlled, Dose-Ranging Trial of Topiramate for Weight Loss in Obesity”,Obesity Research,11:722-733 (2003).
Brookhaven National Laboratory (BNL), “Therapeutic Drug Blocks Nicotine's Effects on Brain Chemistry”, (Nov. 8, 2001), http://www.bnl.gov/bnlweb/pubaf/pr/2001/bnlpr110801.htm.
L. Henderson et al., “J & J will not pursue Topamax for Obesity”,BTech News,(Feb. 8, 2002) (www.btechnews.com).
Johnson et al., “Oral topiramate for treatment of alcohol dependence: a randonmized controlled trial”,Lancet,361(9370): 1666-7 (May 17, 2003).
Lindahl et al., “Characterization of Fluids from the Stomach and Proximal Jejunum in Men and Women”,Pharmaceutical Research,vol. 14, No. 4, pp. 497-502 (1997).
The Physicians' Desk Reference,57thEd., pp. 2501-2503 (2003).
Stein, “Epilepsy Drugs May Curb Obesity”,Wash. Post,p. A03 (Oct. 7, 2003).
Stein, International Diabetes Federation (IDF): Topiramate Shows Potential for Weight Loss Obese Diabetics (Aug. 26, 2003), www.docguide.com
ews/content.nsf
ews/8525697700573E1885256D8E005999FC.

Affiliated with

Also associated with

Rating

Nanoparticulate topiramate formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nanoparticulate topiramate formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nanoparticulate topiramate formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2803214